1. Antiresorptive treatment-associated ONJ
   Evangelos Eleutherakis-Papaiakovou et al, 2017, Eur J Cancer Care CrossRef
2. Zoledronic acid induces micronuclei formation, mitochondrial-mediated apoptosis and cytostasis in kidney cells
   Soma Shiva Nageswara Rao Singireesu et al, 2018, Life Sciences CrossRef
3. Is vitamin d deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study
   Alberto Bedogni et al, 2019, Journal of Cranio-Maxillofacial Surgery CrossRef
4. Systematic evaluation of the mechanisms of zoledronic acid based on network pharmacology.
   Xue-Zhen Liang et al, 2019, Comput Biol Chem CrossRef
5. Current Knowledge, Drug-Based Therapeutic Options and Future Directions in Managing Osteoporosis
   Ali Moshiri et al, 2017, Clinic Rev Bone Miner Metab CrossRef
6. Perimandibular abscess associated with bisphosphonate-related osteonecrosis of the jaw
   Kazuki Ocho et al, 2017, J Gen Fam Med CrossRef
7. Moderate osteoporosis itself is beneficial for bones
   Zhonghua Xiong et al, 2019, Medical Hypotheses CrossRef
8. Bisphosphonates as Supplement to Dental Treatment: A Network Meta-Analysis
   V.F. Zymperdikas et al, 2020, J Dent Res CrossRef
9. Factors influencing severity of medication-related osteonecrosis of the jaw: a retrospective study
   Zhiqiang Feng et al, 2021, Journal of Oral and Maxillofacial Surgery CrossRef
10. A systematic review assessing occurrence of medication-related osteonecrosis of the jaw following dental procedures
    Shimelly Monteiro de Castro Lara et al, 2022, Braz. J. Oral Sci. CrossRef
11. Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study
    Qi-Xuan Yue et al, 2024, J Med Internet Res CrossRef